LEADER 01478nam  2200301z- 450 
001 9910689604203321
005 20161209103624.0
035   $a(CKB)5860000000022944
035   $a(BIP)010647431
035   $a(EXLCZ)995860000000022944
100   $a20220406c2004uuuu  -u-         -
101 0 $aeng
200 10$aFederal and state role in pharmacy compounding and reconstitution $eexploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003
215   $a1 online resource (iii, 145 p.) $cill
311   $a0-16-071522-9 
517   $aFederal and state role in pharmacy compounding and reconstitution 
606   $aDrugs$xDosage forms$zUnited States$xEvaluation
606   $aPharmaceutical industry$zUnited States$xQuality control
610   $aDrugs
610   $aPharmaceutical industry
610   $aMedical
610   $aBusiness & economics
615  0$aDrugs$xDosage forms$xEvaluation.
615  0$aPharmaceutical industry$xQuality control.
906   $aBOOK
912   $a9910689604203321
996   $aFederal and state role in pharmacy compounding and reconstitution$93184282
997   $aUNINA